Resolute Capital Asset Partners’s Ascendis Pharma A/S ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6M	Buy	98,627 +10,000	+11%	+$2.24M	11.87%	1
2025 Q4	$18.9M	Sell	88,627 -77,045	-47%	-$15.9M	9.13%	1
2025 Q3	$32.9M	Buy	165,672 +5,000	+3%	+$933K	17.23%	1
2025 Q2	$27.7M	Sell	160,672 -6,828	-4%	-$1.11M	14.49%	1
2025 Q1	$26.1M	Buy	167,500 +53,000	+46%	+$7.57M	14.69%	1
2024 Q4	$15.8M	Buy	114,500 +10,000	+10%	+$1.31M	8.48%	3
2024 Q3	$15.6M	Buy	104,500 +57,500	+122%	+$7.77M	8.12%	4
2024 Q2	$6.41M	Hold	47,000	–	–	3.69%	9
2024 Q1	$7.11M	Buy	47,000 +10,600	+29%	+$1.51M	3.71%	8
2023 Q4	$4.58M	Sell	36,400 -1,100	-3%	-$110K	2.99%	10
2023 Q3	$3.51M	Hold	37,500	–	–	2.48%	19
2023 Q2	$3.35M	Hold	37,500	–	–	2.38%	18
2023 Q1	$4.02M	Hold	37,500	–	–	2.94%	14
2022 Q4	$4.58M	Buy	37,500 +7,500	+25%	+$871K	4.09%	10
2022 Q3	$3.1M	Buy	30,000 +10,000	+50%	+$948K	2.78%	12
2022 Q2	$1.86M	Hold	20,000	–	–	1.34%	25
2022 Q1	$2.35M	Buy	+20,000	New	+$2.32M	1.5%	27